美國橘皮組織治療市場規模、佔有率、趨勢分析報告：按治療程序、橘皮組織、最終用途、細分市場預測，2025-2033 年

美國橘皮組織治療市場趨勢：

美國橘皮組織治療市場規模預計在 2024 年達到 5.7064 億美元，預計在 2025 年至 2033 年期間的複合年成長率為 9.7%。人們對化妝品和美容護理的日益成長的偏好以及肥胖率的急劇上升正在推動市場擴張。與肥胖相關的社會和心理挑戰，如恥辱感、基於體重的偏見、情緒困擾和自信心下降，已成為主要促進因素。肥胖者經常遭遇霸凌、社會排斥以及教育和就業機會有限。例如，諾和諾德發表的一篇論文強調，肥胖族群在專業和學術環境中經常受到歧視。這種社會壓力對美國對橘皮組織治療的需求不斷成長做出了重大貢獻。

微創手術正日益取代侵入性手術。例如，根據美國整形外科醫師協會的數據，2023年將實施2,540萬例美容微創手術，其中74萬例為非侵入性減脂手術。因此，微創手術的日益普及，加上各種微創治療方案的出現，正在推動美國橘皮組織治療市場的成長。

久坐不動的生活方式和肥胖率的快速上升顯著增加了橘皮組織的盛行率。根據美國疾病管制與預防中心 (CDC) 的數據，近 42% 的美國成年人患有肥胖症，許多州的肥胖率甚至超過 35%。由於過剩的脂肪組織會促進橘皮組織的形成，越來越多的人開始尋求美容治療。隨著人們健康意識的增強和對自我護理的渴望，這一趨勢進一步增強，人們對於無需侵入性手術即可獲得更光滑、更緊緻肌膚的解決方案的需求也日益成長。

近年來，射頻、雷射、超音波、冷凍溶脂以及像 Cellfina 這樣的皮下切割技術等非侵入性和微創技術取得了快速創新，這些技術能夠有效治療，並最大程度縮短恢復期。消費者越來越青睞門診手術以及方便局部/居家治療方案，這些方案既適合他們繁忙的日程安排，又易於獲得。在可支配收入不斷成長和直接面對消費者的教育的推動下，這些技術使橘皮組織治療更加主流且價格合理，從而顯著促進了市場擴張。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國橘皮組織治療市場變數、趨勢與範圍

• 市場展望
  • 母市場展望
  • 相關/附隨市場展望
• 市場動態
  • 市場促進因素分析
  • 市場限制因素分析
• 美國橘皮組織治療市場分析工具
  • 產業分析-波特五力分析
  • PESTEL分析

第4章美國橘皮組織治療市場：治療估計與趨勢分析

• 步驟細分儀表板
• 美國橘皮組織治療市場：治療差異分析
• 美國橘皮組織治療市場規模和趨勢分析（按程序，2021-2033 年）
• 非侵入性治療
• 微創治療
• 局部治療

第5章美國橘皮組織治療市場：橘皮組織評估與趨勢分析

• 橘皮組織細分儀表板
• 美國橘皮組織治療市場：橘皮組織趨勢分析
• 美國橘皮組織治療市場規模及趨勢分析（依橘皮組織，2021-2033）
• 軟脂肪團
• 硬脂肪團
• 水腫性橘皮組織

第6章美國橘皮組織治療市場：最終用途估計與趨勢分析

• 2024年及2033年最終用途市場佔有率
• 最終用途細分儀表板
• 2021 年至 2033 年按應用分類的市場規模、預測與趨勢分析
• 醫院
• 診所及美容中心

第7章 競爭態勢

• 主要市場參與企業的近期趨勢和影響分析
• 公司/競爭對手分類
• 2024年公司市場佔有率分析
• 公司簡介/上市公司
  • Merz Pharma
  • Hologic Inc.（Cynosure）
  • Syneron Medical
  • Zimmer Aesthetics
  • Alma Lasers
  • Cymedics
  • Nubway
  • AbbVie
  • Cutera

U.S. Cellulite Treatment Market Trends:

The U.S. cellulite treatment market size was estimated at USD 570.64 million in 2024 and is expected to grow at a CAGR of 9.7% from 2025 to 2033. The growing preference for cosmetic and aesthetic treatments, along with a surge in obesity rates, is propelling market expansion. Social and psychological challenges linked to obesity such as stigma, weight-based prejudice, emotional distress, and reduced self-confidence are emerging as key drivers. Individuals with obesity frequently encounter bullying, social exclusion, and limited access to educational and employment opportunities. For example, a publication by Novo Nordisk highlights that people with obesity are often discriminated against in professional and academic settings. These societal pressures are significantly contributing to the rising demand for cellulite treatment solutions in the U.S.

Minimally invasive surgeries are rapidly replacing invasive surgeries. For instance, according to American Society of Plastic Surgeons, 25.4 million cosmetic minimally-invasive procedures were carried out in 2023, out of which 0.74 million were Non-invasive fat reduction procedures. Thus, increasing adoption of minimally invasive surgeries, coupled with availability of a wide range of minimally invasive treatment options, is driving the growth of the U.S. cellulite treatment market.

A surge in sedentary lifestyles and obesity has significantly increased the prevalence of cellulite. According to the CDC, nearly 42% of U.S. adults were obese, with many states showing obesity rates exceeding 35%. Excess adipose tissue contributes to the development of cellulite, prompting more individuals to seek cosmetic treatments. This trend is further reinforced by growing health consciousness and a desire for self-care, translating into increased demand for solutions that offer smoother, more toned skin even in the absence of invasive surgery.

Recent years have seen rapid innovation in non-invasive and minimally invasive technologies such as radiofrequency, laser, ultrasound, cryolipolysis, and subcision techniques such as Cellfina offering effective results with minimal downtime. Consumers increasingly favor outpatient procedures and topical/home treatment options that align with busy schedules and ease of access. These technologies, supported by rising disposable incomes and direct-to-consumer education, have made cellulite treatments more mainstream and affordable, significantly driving market expansion.

U.S. Cellulite Treatment Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. cellulite treatment market report on the basis of procedure, cellulite, and end use:

• Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Non-Invasive Treatment
• Minimally Invasive Treatment
• Topical Treatment
• Cellulite Outlook (Revenue, USD Million, 2021 - 2033)
• Soft Cellulite
• Hard Cellulite
• Edematous Cellulite
• End UseOutlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Clinics and Beauty Centers

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Procedure
  • 1.2.2. Cellulite
  • 1.2.3. End Use
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Procedure outlook
  • 2.2.2. Cellulite outlook
  • 2.2.3. End Use outlook
• 2.3. Competitive scenario

Chapter 3. U.S. Cellulite Treatment Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. Cellulite Treatment Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. U.S. Cellulite Treatment Market: Procedure Estimates & Trend Analysis

• 4.1. Procedure Segment Dashboard
• 4.2. U.S. Cellulite Treatment Market: Procedure Movement Analysis
• 4.3. U.S. Cellulite Treatment Market Size & Trend Analysis, By Procedure, 2021 to 2033 (USD Million)
• 4.4. Non-Invasive Treatment
  • 4.4.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 4.5. Minimally Invasive Treatment
  • 4.5.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 4.6. Topical Treatment
  • 4.6.1. Market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 5. U.S. Cellulite Treatment Market: Cellulite Estimates & Trend Analysis

• 5.1. Cellulite Segment Dashboard
• 5.2. U.S. Cellulite Treatment Market: Cellulite Movement Analysis
• 5.3. U.S. cellulite treatment market Size & Trend Analysis, By Cellulite, 2021 to 2033 (USD Million)
• 5.4. Soft Cellulite
  • 5.4.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 5.5. Hard Cellulite
  • 5.5.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 5.6. Edematous Cellulite
  • 5.6.1. Market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 6. U.S. Cellulite Treatment Market: End Use Estimates & Trend Analysis

• 6.1. End Use Market Share, 2024 & 2033
• 6.2. End Use Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, By End Use, 2021 to 2033 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Market estimates and forecasts 2021 - 2033 (USD Million)
• 6.5. Clinics and Beauty Centers
  • 6.5.1. Market estimates and forecasts 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
• 7.3. Company market share analysis, 2024
• 7.4. Company Profiles/Listing
  • 7.4.1. Merz Pharma
    • 7.4.1.1. Company overview
    • 7.4.1.2. Financial performance
    • 7.4.1.3. Procedure benchmarking
    • 7.4.1.4. Strategic initiatives
  • 7.4.2. Hologic Inc. (Cynosure)
    • 7.4.2.1. Company overview
    • 7.4.2.2. Financial performance
    • 7.4.2.3. Procedure benchmarking
    • 7.4.2.4. Strategic initiatives
  • 7.4.3. Syneron Medical
    • 7.4.3.1. Company overview
    • 7.4.3.2. Financial performance
    • 7.4.3.3. Procedure benchmarking
    • 7.4.3.4. Strategic initiatives
  • 7.4.4. Zimmer Aesthetics
    • 7.4.4.1. Company overview
    • 7.4.4.2. Financial performance
    • 7.4.4.3. Procedure benchmarking
    • 7.4.4.4. Strategic initiatives
  • 7.4.5. Alma Lasers
    • 7.4.5.1. Company overview
    • 7.4.5.2. Financial performance
    • 7.4.5.3. Procedure benchmarking
    • 7.4.5.4. Strategic initiatives
  • 7.4.6. Cymedics
    • 7.4.6.1. Company overview
    • 7.4.6.2. Financial performance
    • 7.4.6.3. Procedure benchmarking
    • 7.4.6.4. Strategic initiatives
  • 7.4.7. Nubway
    • 7.4.7.1. Company overview
    • 7.4.7.2. Financial performance
    • 7.4.7.3. Procedure benchmarking
    • 7.4.7.4. Strategic initiatives
  • 7.4.8. AbbVie
    • 7.4.8.1. Company overview
    • 7.4.8.2. Financial performance
    • 7.4.8.3. Procedure benchmarking
    • 7.4.8.4. Strategic initiatives
  • 7.4.9. Cutera
    • 7.4.9.1. Company overview
    • 7.4.9.2. Financial performance
    • 7.4.9.3. Procedure benchmarking
    • 7.4.9.4. Strategic initiatives

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. cellulite treatment market, by Procedure, 2021 - 2033 (USD Million)
• Table 3 U.S. cellulite treatment market, by Cellulite, 2021 - 2033 (USD Million)
• Table 4 U.S. cellulite treatment market, by End Use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. Cellulite Treatment Market: market outlook
• Fig. 10 U.S. Cellulite Treatment Market competitive insights
• Fig. 11 Parent market outlook
• Fig. 12 Related/ancillary market outlook
• Fig. 13 Penetration and growth prospect mapping
• Fig. 14 Industry value chain analysis
• Fig. 15 U.S. cellulite treatment market driver impact
• Fig. 16 U.S. cellulite treatment market restraint impact
• Fig. 17 U.S. cellulite treatment market strategic initiatives analysis
• Fig. 18 U.S. cellulite treatment market: Procedure movement analysis
• Fig. 19 U.S. cellulite treatment market: Procedure outlook and key takeaways
• Fig. 20 Non-Invasive Treatment market estimates and forecast, 2021 - 2033
• Fig. 21 Minimally Invasive Treatment market estimates and forecast, 2021 - 2033
• Fig. 22 U.S. Cellulite Treatment Market: Cellulite movement analysis
• Fig. 23 U.S. Cellulite Treatment Market: Cellulite outlook and key takeaways
• Fig. 24 Soft Cellulite market estimates and forecast, 2021 - 2033
• Fig. 25 Hard Cellulite market estimates and forecast, 2021 - 2033
• Fig. 26 U.S. Cellulite Treatment Market: End Use movement analysis
• Fig. 27 U.S. Cellulite Treatment Market: End Use outlook and key takeaways
• Fig. 28 Hospitals market estimates and forecast, 2021 - 2033
• Fig. 29 Clinics and Beauty Centers market estimates and forecast, 2021 - 2033